Anti-Proteasome 20S LMP7 抗体
Anti-Proteasome 20S LMP7 antibody
4
(12 Reviews)
|
(65 Publications)
Rabbit Polyclonal Proteasome 20S LMP7 antibody. Suitable for ICC, WB and reacts with Human samples. Cited in 65 publications. Immunogen corresponding to Synthetic Peptide within Human PSMB8 aa 250 to C-terminus.
別名を表示する
LMP7, PSMB5i, RING10, Y2, PSMB8, Proteasome subunit beta type-8, Low molecular mass protein 7, Macropain subunit C13, Multicatalytic endopeptidase complex subunit C13, Proteasome component C13, Proteasome subunit beta-5i, Really interesting new gene 10 protein
- ICC
Supplier Data
Immunocytochemistry - Anti-Proteasome 20S LMP7 antibody (AB3329)
Immunocytochemistry/ Immunofluorescence analysis of HeLa cells labeling Proteasome 20S LMP7 with ab3329 at 5μg/ml. The cells were fixed with 4% paraformaldehyde for 15 minutes, permeabilized with 0.1% Triton X-100 in TBS for 10 minutes, and blocked with 3% Blocker BSA in PBS for 15 minutes at room temperature. Cells were stained with or without Anti-Proteasome 20S LMP7 antibody (ab3329), at a concentration of 5μg/ml for 1 hour at room temperature, and then incubated with a Alexa Fluor® 488 goat anti-rabbit IgG secondary antibody at a dilution of 1/1000 for 1 hour s at room temperature (both panels, green). Nuclei (both panels, blue) were stained with Hoechst 33342 dye.
- ICC
Unknown
Immunocytochemistry - Anti-Proteasome 20S LMP7 antibody (AB3329)
ICC/IF image of ab3329 stained MCF7 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab3329, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- WB
Supplier Data
Western blot - Anti-Proteasome 20S LMP7 antibody (AB3329)
Detected by chemiluminescence.
All lanes:
Western blot - Anti-Proteasome 20S LMP7 antibody (ab3329) at 2 µg/mL
Lane 1:
HeLa whole cell extracts at 30 µg
Lane 2:
HeLa treated with IFN gamma (100ng/ml IFN gamma for 72h) whole cell extracts at 30 µg
Lane 3:
U-937 whole cell extracts at 30 µg
Lane 4:
Raji whole cell extracts at 30 µg
Lane 5:
Ramos whole cell extracts at 30 µg
Secondary
All lanes:
Goat anti-Rabbit IgG (H+L) HRP conjugate at 1/2500 dilution
Predicted band size: 30 kDa
Observed band size: 20 kDa
false
- WB
Unknown
Western blot - Anti-Proteasome 20S LMP7 antibody (AB3329)
Western blot of proteasome 20S LMP7 from HeLa cell extract using ab3329.
All lanes:
Western blot - Anti-Proteasome 20S LMP7 antibody (ab3329)
Predicted band size: 30 kDa
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The immunoproteasome in which LMP7 is an essential component plays an important role in the adaptive immune system. It influences the generation of antigenic peptides that are presented on MHC class I molecules. LMP7's expression is increased during immune responses particularly following gamma interferon (IFN-γ) stimulation contributing to the immune-mediated proteasome conformation. The immunoproteasome enables more efficient peptide processing enhancing antigen presentation to cytotoxic T lymphocytes.
Pathways
LMP7 is involved in the MHC class I antigen presentation pathway. This pathway allows the immune system to detect and respond to intracellular pathogens such as viruses. Additionally LMP7 interacts with TAP (Transporter associated with Antigen Processing) and other proteasome subunits to ensure effective peptide processing for loading onto MHC class I molecules. Through this involvement it closely links to immune signaling and cellular stress responses.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (65)
Recent publications for all applications. Explore the full list and refine your search
Nature 644:516-526 PubMed40681898
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 17: PubMed40507366
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:111873 PubMed40060909
2025
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 122:e2419607122 PubMed39964708
2025
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy 21:1212-1227 PubMed39878121
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 21:191 PubMed39095788
2024
Applications
Unspecified application
Species
Unspecified reactive species
Arteriosclerosis, thrombosis, and vascular biology 44:1346-1364 PubMed38660806
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer 22:196 PubMed38049829
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37895057
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:4092 PubMed37433777
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com